Creative Biolabs Vaccine Blog Creative Biolabs Vaccine Blog

Menu

Skip to content
  • Vaccine Research
  • Popular Vaccine
  • Vaccine News

Vaccine Development Services

Creative Biolabs effectively supports the vaccine industry with a full range of vaccine design and production services and related products.

Know More

Vaccine Technologies

Creative Biolabs focuses on all kinds of Vaccine Technologies that include Vaccine Target Validation, Monoclonal Antibody Vaccines, Cell Based Vaccines and more.

Know More
06Dec/22

Updates in Rabies Vaccine: Lifelong Immunity Might Be Achieved

December 6, 2022Vaccine ResearchRabies Vaccine, Vaccines for Lyssavirusbiovaccine

Untreated rabies infection is almost 100 percent fatal, killing between 50000 and 60000 people a year, many of whom are children. Rabies vaccine for human use consists of inactivated virus, which hasRead More…

27Oct/22

Nature: Cancer Vaccine, the Next Frontier of Immunotherapy

October 27, 2022Vaccine Reviewantigen vaccine, cancer vaccinebiovaccine

Traditional vaccines are committed to the prevention of a variety of infectious diseases, while cancer vaccines, which have attracted much attention in recent years, aim to focus the strength of the humanRead More…

10Oct/22

Tumors: Adenovirus Vector Vaccine Makes Immunotherapy “Powerful”!

October 10, 2022Vaccine ResearchAdenovirus Vector Vaccine, cancer vaccine, GAd Vaccines, Neoantigen Vaccinebiovaccine

Adenovirus (Ad) vector vaccines have been frequently reported in recent years as the main force against COVID-19. In fact, Ad vaccines have a wide range of applications, and also play an importantRead More…

14Sep/22

Nature: Custom New Antigen Tumor Vaccine Research Progress and Challenges

September 14, 2022Vaccine News, Vaccine ResearchNew Immunogenic Antigens, tumor vaccinebiovaccine

Vaccines have traditionally been used to prevent infectious diseases. However, the ability of this drug to induce and amplify antigen-specific immune responses has long been considered a potentially valuable tool for cancerRead More…

31Jul/22

Sci Immunol: Why Vaccines Against Malaria Quickly Lose Their Protective Effects

July 31, 2022Vaccine NewsMalaria Vaccinebiovaccine

In a study published in the international journal Science Immunology titled “Clonal evolution and TCR specificity of the human TFH cell response to Plasmodium falciparum CSP”, scientists from the German Cancer ResearchRead More…

27Jun/22

Nature: Influenza Vaccine Can Reduce Severe Illness From COVID-19 by 90%!

June 27, 2022Vaccine News, Vaccine ResearchInfluenza Vaccine, Novel Coronavirusbiovaccine

Recently, the research team of Doha Cornell Medical Center published the research results entitled “Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar” on the medRxiv. The study foundRead More…

27Jun/22

News and Facts About Monkeypox Virus

June 27, 2022Popular Vaccine, Vaccine NewsMonkeypox Vaccine, Smallpox Vaccinebiovaccine

Monkeypox is a rare viral infectious disease similar to human smallpox caused by monkeypox virus. It is also a zoonosis. Mainly found in the rainforest regions of central and western Africa. ItRead More…

19May/22

Spherical Nucleic Acid Vaccine—Amazing Vaccine Candidate

May 19, 2022Vaccine News, Vaccine ResearchAdjuvant, COVID-19 Vaccine, Nucleic Acid Vaccinebiovaccine

Under the background of the global COVID-19 pandemic, amazing progress has been made in the field of vaccine research and development, and there are more and more different types of vaccines basedRead More…

22Apr/22

Cell Rep: mRNA Vaccine Technology May Help to Develop New HIV Vaccines

April 22, 2022Vaccine News, Vaccine ResearchHIV vaccine, vaccine development, ZK Vaccinebiovaccine

Using nucleoside modified mRNAs in lipid nanoparticles (mRNA-LNP) as a vaccine for COVID-19 may successfully predict a new era of vaccine development. For HIV-1, polyvalent enveloped trimer protein nanoparticles may be usedRead More…

11Apr/22

Respiratory Syncytial Virus (RSV) Vaccine: Breakthrough Therapy RSVpreF Approved by FDA

April 11, 2022Vaccine ResearchRSV vaccine, RSVpreF, subunit vaccinebiovaccine

Recently, the US Food and Drug Administration (FDA) has granted respiratory syncytial virus (RSV) bivalent pre-fused F subunit vaccine (RSVpreF) breakthrough therapy recognition (BTD), which is an active immunization for the pregnantRead More…

Posts navigation

  • « Previous
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next »

Categories

  • Popular Vaccine
  • Uncategorized
  • Vaccine News
  • Vaccine Research
  • Vaccine Review

Recent Posts

  • A Vaccine Central in H5 Antigenic Space Confers Broad Immunity
  • TB Protection: A Novel Trivalent mRNA Vaccine Mined from the Human CD4 Antigen Repertoire
  • The mRNA Revolution: A New Era of Medicine is Here
  • Dental Floss Vaccine Emerges: Needle-Free, Painless, and Flu-Preventive!
  • Blueprint for the First F. buski Vaccine

Archives

Contact Us

USA - UK
Copyright © Creative Biolabs Vaccine Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Vaccine Research
  • Popular Vaccine
  • Vaccine News